A phase 2 study of neoadjuvant chemotherapy with gemcitabine, epirubicin and paclitaxel (Taxol)[GET] in locally advanced breast cancer
Phase of Trial: Phase II
Latest Information Update: 01 Dec 2008
At a glance
- Drugs Epirubicin (Primary) ; Gemcitabine (Primary) ; Paclitaxel (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 01 Dec 2008 Last checked against ClinicalTrials.gov record.
- 11 May 2007 New trial record.